In the latest restructuring, Genentech will lose 29-year veteran Vishva Dixit, the vice president of its physiological chemistry unit; Todd McDevitt, head of cell therapy, and Man-Wah Tan, a vice ...

A newly unsealed whistleblower lawsuit accuses Novartis and Genentech of being at the center of a decades-long kickback ...

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

“Dr. Sanders has an exceptional track record in developing new technologies,” said Calidi Chairman of the Board Jim Schoeneck. “We believe her deep expertise in the clinical development of novel ...

Previously a professor at the Massachusetts Institute of Technology and a leader at the Broad Institute of M.I.T. and Harvard ...

Genentech is working with Congress and the Centers for Medicare and Medicaid Services (CMS) to offer suggestions for changes to IRA. But the company is considering legal action as well, CEO Alexander ...

Drug manufacturer Genentech has added to its South San Francisco campus just weeks after it announced layoffs at its headquarters at 1 DNA Way. The firm bought the location of culinary school San ...

A company competing with Novartis and Merck to treat people with chronic myeloid leukemia moved from Colorado to the Bay Area ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), the Breast International Group (BIG), Institut Jules Bordet Clinical Trials Support ...